N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus

Traumatic brain injury induces neuroinflammation and neuronal degeneration that is associated with escalated alcohol self-administration in rats

(2015) Jacques P. Mayeux et al.   BEHAVIOURAL BRAIN RESEARCH

Neuronal Circuits for Fear Expression and Recovery: Recent Advances and Potential Therapeutic Strategies

(2015) Cyril Dejean et al.   BIOLOGICAL PSYCHIATRY

Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence

(2015) Sabrina F. Lisboa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels

(2014) D.C. Aguiar et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis

(2014) Andrea Navarria et al.   PHARMACOLOGICAL RESEARCH

Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats

(2013) A.F. Almeida-Santos et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

N-Arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze

(2012) Catherine S. John et al.   BEHAVIOURAL BRAIN RESEARCH

The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior

(2012) Manoela V. Fogaça et al.   NEUROPHARMACOLOGY

Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission

(2012) Alejandro Aparisi Rey et al.   NEUROPSYCHOPHARMACOLOGY

Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats

(2012) Manoela V. Fogaça et al.   PSYCHOPHARMACOLOGY

Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

(2011) Plínio C Casarotto et al.   NEUROPSYCHOPHARMACOLOGY

Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety—two sides of one coin?

(2011) F.A. Moreira et al.   NEUROSCIENCE

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus

(2009) Carolina J.P.A. Santos et al.   BEHAVIOURAL PHARMACOLOGY

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

(2009) Alline Cristina Campos et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

(2008) Rafael M. Bitencourt et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray

(2008) Ana Luisa B. Terzian et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

(2008) Vincenzo Micale et al.   NEUROPSYCHOPHARMACOLOGY

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

(2007) T. Rubino et al.   NEUROPHARMACOLOGY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY